Body mass index
|
0.100 |
GeneticVariation
|
phenotype |
GWASCAT |
Meta-analysis of genome-wide association studies for body fat distribution in 694 649 individuals of European ancestry.
|
30239722 |
2019 |
Body mass index
|
0.100 |
GeneticVariation
|
phenotype |
GWASCAT |
Leveraging Polygenic Functional Enrichment to Improve GWAS Power.
|
30595370 |
2019 |
Atypical femoral fracture
|
0.100 |
GeneticVariation
|
phenotype |
GWASCAT |
A Genome-Wide Association Study of Bisphosphonate-Associated Atypical Femoral Fracture.
|
31006051 |
2019 |
Parathyroid hormone measurement
|
0.100 |
GeneticVariation
|
phenotype |
GWASCAT |
Genome-wide meta-analysis identifies novel loci associated with parathyroid hormone level.
|
30134803 |
2018 |
Body mass index
|
0.100 |
GeneticVariation
|
phenotype |
GWASCAT |
A Large Multiethnic Genome-Wide Association Study of Adult Body Mass Index Identifies Novel Loci.
|
30108127 |
2018 |
Body mass index
|
0.100 |
GeneticVariation
|
phenotype |
GWASCAT |
Genetic studies of body mass index yield new insights for obesity biology.
|
25673413 |
2015 |
AMYOTROPHIC LATERAL SCLEROSIS 6 (disorder)
|
0.100 |
GeneticVariation
|
disease |
GWASCAT |
Genome-wide association study combining pathway analysis for typical sporadic amyotrophic lateral sclerosis in Chinese Han populations.
|
24529757 |
2014 |
AMYOTROPHIC LATERAL SCLEROSIS 1
|
0.100 |
GeneticVariation
|
disease |
GWASCAT |
Genome-wide association study combining pathway analysis for typical sporadic amyotrophic lateral sclerosis in Chinese Han populations.
|
24529757 |
2014 |
Amyotrophic Lateral Sclerosis, Sporadic
|
0.100 |
GeneticVariation
|
disease |
GWASCAT |
Genome-wide association study combining pathway analysis for typical sporadic amyotrophic lateral sclerosis in Chinese Han populations.
|
24529757 |
2014 |
AMYOTROPHIC LATERAL SCLEROSIS 1, AUTOSOMAL RECESSIVE
|
0.100 |
GeneticVariation
|
disease |
GWASCAT |
Genome-wide association study combining pathway analysis for typical sporadic amyotrophic lateral sclerosis in Chinese Han populations.
|
24529757 |
2014 |
Migraine Disorders
|
0.100 |
GeneticVariation
|
group |
GWASDB |
Genome-wide meta-analysis identifies new susceptibility loci for migraine.
|
23793025 |
2013 |
Migraine Disorders
|
0.100 |
GeneticVariation
|
group |
GWASCAT |
Genome-wide meta-analysis identifies new susceptibility loci for migraine.
|
23793025 |
2013 |
Schizophrenia
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
SH3GL2 and CLVS1 genes were associated with suicidal ideation in SCZ (p = 5.62e-08 and 0.01, respectively), the former also in the meta-analysis (p = .01).
|
30149091 |
2019 |
Central Diabetes Insipidus
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
Low serum albumin and genes RLBP1L1 and ASPH located on chromosome 8 and ATP7B on chromosome 13 were associated with CDI.
|
29594489 |
2018 |
Rhabdomyoma
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
The RT-PCR expression pattern of 16 adult human tissues indicated that CRALBPL was only expressed in brain, while it was expressed in all of seven human carcinoma cell lines we used, especially in human gastric adenocarcinoma cell line, human rhabdomyoma cell line, human hepatocellular carcinoma (HCC) cell line, and human prostatic carcinoma cell line.
|
18271718 |
2008 |
Liver carcinoma
|
0.010 |
Biomarker
|
disease |
BEFREE |
Our results show that CRALBPL may be used as a marker for human HCCs.
|
18271718 |
2008 |
Liver carcinoma
|
0.010 |
Biomarker
|
disease |
LHGDN |
Our results show that CRALBPL may be used as a marker for human HCCs.
|
18271718 |
2008 |